rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-18
|
pubmed:abstractText |
Transarterial chemoembolization (TACE) has long been used as a palliative therapy for unresectable hepatocellular carcinoma (HCC). High-dose hepatic arterial infusion chemotherapy (HAIC) has showed favorable outcomes in patients with intractable, advanced HCC. The aim of this study was to compare the effectiveness and safety of high-dose HAIC and conventional TACE using doxorubicin for advanced HCC.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1738-222X
|
pubmed:author |
pubmed-author:BaeSi HyunSH,
pubmed-author:ChoiJong YoungJY,
pubmed-author:HanKwang HyubKH,
pubmed-author:HwangJae SeokJS,
pubmed-author:JangByoung KukBK,
pubmed-author:KimHee YeonHY,
pubmed-author:KimJin DongJD,
pubmed-author:KimSang GyuneSG,
pubmed-author:KimYoung SeokYS,
pubmed-author:Korean Liver Cancer Study Group,
pubmed-author:ParkJun YongJY,
pubmed-author:SeoYeon SeokYS,
pubmed-author:UmSoon HoSH,
pubmed-author:WooHyun YoungHY,
pubmed-author:YimHyung JoonHJ,
pubmed-author:YoonSeung KewSK
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
355-61
|
pubmed:meshHeading |
pubmed-meshheading:21415578-Antibiotics, Antineoplastic,
pubmed-meshheading:21415578-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21415578-Carcinoma, Hepatocellular,
pubmed-meshheading:21415578-Chemoembolization, Therapeutic,
pubmed-meshheading:21415578-Cisplatin,
pubmed-meshheading:21415578-Doxorubicin,
pubmed-meshheading:21415578-Fluorouracil,
pubmed-meshheading:21415578-Humans,
pubmed-meshheading:21415578-Infusions, Intra-Arterial,
pubmed-meshheading:21415578-Liver Neoplasms,
pubmed-meshheading:21415578-Magnetic Resonance Imaging,
pubmed-meshheading:21415578-Prospective Studies,
pubmed-meshheading:21415578-Retrospective Studies,
pubmed-meshheading:21415578-Severity of Illness Index,
pubmed-meshheading:21415578-Survival Rate,
pubmed-meshheading:21415578-Tomography, X-Ray Computed
|
pubmed:year |
2010
|
pubmed:articleTitle |
A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.
|
pubmed:affiliation |
Department of Internal Medicine, The Catholic University of Korea School of Medicine, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|